These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Non-invasive tests for liver fibrosis: encouraging or discouraging results? Burroughs AK; Cholongitas E J Hepatol; 2007 May; 46(5):751-5. PubMed ID: 17383047 [No Abstract] [Full Text] [Related]
3. Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis? Hashimoto E; Farrell GC J Gastroenterol Hepatol; 2009 Apr; 24(4):501-3. PubMed ID: 19368628 [No Abstract] [Full Text] [Related]
4. Nonalcoholic steatohepatitis. Williams CN Can J Gastroenterol; 1999 Oct; 13(8):639-40. PubMed ID: 10545649 [No Abstract] [Full Text] [Related]
5. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study. de Lédinghen V; Ratziu V; Causse X; Le Bail B; Capron D; Renou C; Pilette C; Oules V; Gelsi E; Oberti F; Vallet-Pichard A; Le Provost N; Cadranel JF; ; J Hepatol; 2006 Oct; 45(4):592-9. PubMed ID: 16837098 [TBL] [Abstract][Full Text] [Related]
7. Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease. Adams LA; Angulo P Clin Liver Dis; 2007 Feb; 11(1):25-35, viii. PubMed ID: 17544970 [TBL] [Abstract][Full Text] [Related]
8. Pediatric initiatives within the Nonalcoholic Steatohepatitis-Clinical Research Network (NASH CNR). Lavine JE; Schwimmer JB; J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):220-1. PubMed ID: 12971361 [No Abstract] [Full Text] [Related]
9. Hematocrit is associated with fibrosis in patients with nonalcoholic steatohepatitis. Li Y; Liu L; Wang B; Wang J; Chen D Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):332-8. PubMed ID: 24172912 [TBL] [Abstract][Full Text] [Related]
15. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Diehl AM; Goodman Z; Ishak KG Gastroenterology; 1988 Oct; 95(4):1056-62. PubMed ID: 3410220 [TBL] [Abstract][Full Text] [Related]
16. Interaction of serum ferritin and body mass index in patients with chronic hepatitis B: improved prediction of cirrhosis. Paul S; O'Regan K; St John A; Stuart K; Crawford D Hepatology; 2013 May; 57(5):2094-5. PubMed ID: 22987244 [No Abstract] [Full Text] [Related]
17. [Percutaneous liver biopsy in diabetics--experiences between 1968 and 1971]. Schmidt R; Tennstedt A Z Arztl Fortbild (Jena); 1974 Mar; 68(6):298-302. PubMed ID: 4418773 [No Abstract] [Full Text] [Related]
18. Behaviour of antithrombin 3 in liver disease. Duckert F Scand J Gastroenterol Suppl; 1973; 19():109-12. PubMed ID: 4515632 [No Abstract] [Full Text] [Related]
19. Late nonalcoholic fatty liver disease with cirrhosis: a pathologic case of lost or mistaken identity. Lefkowitch JH; Morawski JL Semin Liver Dis; 2012 Feb; 32(1):92-8. PubMed ID: 22418891 [TBL] [Abstract][Full Text] [Related]